We all know, in theory, that our time is limited. Living that reality means truly cherishing the time we have, not fretting about the things we can’t change and learning to value time on our own.
Study examines the comparative cardiovascular efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes.
Reducing the viral load in the oral cavity can potentially mitigate the spread of the virus within the body and curb transmission to other people, according to the authors.
What Canadian healthcare needs is feedback from doctors, nurses, pharmacists, social workers, data managers, economists and patients (and their families).